Certificate Number

GMPC or Non Compliance

Site Name

Site Address

City

Postcode

Country

Total Records 21 to 30 of 67
Download
GMP Search Results
Certificate Number GMPC or Non-compliance Site Details Country Inspection Date
UK MIA 57242 Insp GMP 57242/30800659-0001[H] GMPC

MODERNA BIOTECH DISTRIBUTOR UK LTD, 123 VICTORIA STREET, LONDON, SW1E 6DE, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 17328 Insp IMP 17328/23930512-0005[I] GMPC

ZAYED CENTRE FOR RESEARCH INTO RARE DISEASE IN CHILDREN, 20 GUILFORD STREET, LONDON, WC1N 1DZ, UNITED KINGDOM

UNITED KINGDOM
UK MIA 53797 Insp GMP 53797/24120983-0003[H] GMPC

AUSTIN MCNEIL LIMITED, 772 FULHAM ROAD, LONDON, SW6 5SJ, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 735 Insp IMP 22804/661963-0007[I] GMPC

BOC LIMITED, 28 DEER PARK ROAD, LONDON, SW19 3UF, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 15140 Insp IMP 15140/671693-0017[I] GMPC

HAMMERSMITH MEDICINES RESEARCH LIMITED, CUMBERLAND AVENUE, LONDON, NW10 7EW, UNITED KINGDOM

UNITED KINGDOM
UK MIA 22352 Insp GMP 22352/12678305-0007[H] GMPC

VERTEX PHARMACEUTICALS (EUROPE) LIMITED, LEVEL 9, PADDINGTON CENTRAL, 2 KINGDOM STREET, LONDON, W2 6BD, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 22352 Insp IMP 22352/12678305-0005[I] GMPC

VERTEX PHARMACEUTICALS (EUROPE) LIMITED, LEVEL 9, PADDINGTON CENTRAL, 2 KINGDOM STREET, LONDON, W2 6BD, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 17328 Insp GMP/IMP 17328/2091287-0006[I] GMPC

GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST, GENE AND CELL THERAPY, GREAT ORMOND STREET, LONDON, WC1N 3JH, UNITED KINGDOM

UNITED KINGDOM
UK MIA 35682 Insp GMP/GDP 35682/14951420-0006[H] GMPC

FAIRVIEW HEALTH LIMITED, FAIRVIEW HOUSE, UNIT 19, NCR BUSINESS CENTRE, GREAT CENTRAL WAY, LONDON, NW10 0AB, UNITED KINGDOM

UNITED KINGDOM
UK MIA 16378 Insp GMP/GDP 16378/21662509-0003[H] GMPC

BEACHCOURSE LIMITED, UNITS 2 & 3, TOWNSEND INDUSTRIAL ESTATE, WAXLOW ROAD, LONDON, NW10 7NU, UNITED KINGDOM

UNITED KINGDOM

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX